share_log

6-K: Novo Nordisk A/S - Share Repurchase Programme

6-K: Novo Nordisk A/S - Share Repurchase Programme

诺和诺德 | 6-K：诺和诺德-股票回购计划
美股sec公告 ·  06/10 09:33
Moomoo AI 已提取核心信息
Novo Nordisk A/S, a leading global healthcare company, has announced the continuation of its share repurchase program, which began on February 6, 2024. As part of a 12-month plan to buy back shares worth up to DKK 20 billion, the company initiated a specific repurchase phase on May 6, 2024, with the intention to acquire B shares for up to DKK 2.2 billion between May 7, 2024, and August 5, 2024. Since the last update on June 3, 2024, Novo Nordisk has purchased an additional 154,000 B shares at an average price of DKK 950.28, amounting to a total transaction value of DKK 146,319,451. This brings the accumulated repurchases under the current program to 786,545 B shares, totaling DKK 724,234,837. As of June 7, 2024, the company has acquired 9,520,795 B shares at an average price of DKK 866.73 since the beginning of the repurchase plan, representing a total spend of DKK 8,251,969,609. Novo Nordisk now holds 10,886,359 B shares as treasury shares, which is 0.2% of the share capital. The company's shares are traded on Nasdaq Copenhagen and the New York Stock Exchange.
Novo Nordisk A/S, a leading global healthcare company, has announced the continuation of its share repurchase program, which began on February 6, 2024. As part of a 12-month plan to buy back shares worth up to DKK 20 billion, the company initiated a specific repurchase phase on May 6, 2024, with the intention to acquire B shares for up to DKK 2.2 billion between May 7, 2024, and August 5, 2024. Since the last update on June 3, 2024, Novo Nordisk has purchased an additional 154,000 B shares at an average price of DKK 950.28, amounting to a total transaction value of DKK 146,319,451. This brings the accumulated repurchases under the current program to 786,545 B shares, totaling DKK 724,234,837. As of June 7, 2024, the company has acquired 9,520,795 B shares at an average price of DKK 866.73 since the beginning of the repurchase plan, representing a total spend of DKK 8,251,969,609. Novo Nordisk now holds 10,886,359 B shares as treasury shares, which is 0.2% of the share capital. The company's shares are traded on Nasdaq Copenhagen and the New York Stock Exchange.
领先的全球医疗保健公司诺和诺德已宣布继续进行股份回购计划，该计划始于2024年2月6日。作为一项为期12个月的计划，诺和诺德计划回购价值高达200亿丹麦克朗的股票，公司于2024年5月6日启动特定回购阶段，并打算在2024年5月7日至2024年8月5日之间收购不超过22亿丹麦克朗的B类股。自2024年6月3日以来，诺和诺德已以平均价格950.28丹麦克朗购买了额外的154,000股B类股，总交易金额为1.46319451亿丹麦克朗。这使当前计划下的累计回购股票达到了786,545股B类股，总计达到了7.24234837亿丹麦克朗。截至2024年6月7日，自回购计划开始以来，诺和诺德已以平均价格866.73丹麦克朗收购了9520795股B类股，总花费为82.519696.9609亿丹麦克朗。诺和诺德目前持有10,886,359股B类股作为财务股，占股本的0.2%。该公司的股票在纳斯达克哥本哈根交易所和纽约证券交易所上市。
领先的全球医疗保健公司诺和诺德已宣布继续进行股份回购计划，该计划始于2024年2月6日。作为一项为期12个月的计划，诺和诺德计划回购价值高达200亿丹麦克朗的股票，公司于2024年5月6日启动特定回购阶段，并打算在2024年5月7日至2024年8月5日之间收购不超过22亿丹麦克朗的B类股。自2024年6月3日以来，诺和诺德已以平均价格950.28丹麦克朗购买了额外的154,000股B类股，总交易金额为1.46319451亿丹麦克朗。这使当前计划下的累计回购股票达到了786,545股B类股，总计达到了7.24234837亿丹麦克朗。截至2024年6月7日，自回购计划开始以来，诺和诺德已以平均价格866.73丹麦克朗收购了9520795股B类股，总花费为82.519696.9609亿丹麦克朗。诺和诺德目前持有10,886,359股B类股作为财务股，占股本的0.2%。该公司的股票在纳斯达克哥本哈根交易所和纽约证券交易所上市。
有用
没用

该公告为独立文件：

独立文件1  查看翻译

声明：本内容仅用作提供资讯及教育之目的，不构成对任何特定投资或投资策略的推荐或认可。 更多信息